HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Salomon Yves Cohen Selected Research

Intravitreal Injections

3/2015Occurrence of macular hematoma after ranibizumab treatment for age-related macular degeneration.
1/2014Bimonthly ranibizumab for neovascular age-related macular degeneration.
9/2010Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin(®) ) in neovascular age-related macular degeneration.
1/2009Intravitreal ranibizumab for choroidal neovascularization secondary to choroidal nevus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Salomon Yves Cohen Research Topics

Disease

11Macular Degeneration (Age-Related Maculopathy)
01/2023 - 10/2003
8Choroidal Neovascularization
01/2023 - 10/2003
3Atrophy
01/2023 - 09/2010
3Macular Edema
11/2022 - 01/2017
2Retinal Detachment (Retinal Detachments)
11/2023 - 05/2012
2Angioid Streaks
01/2023 - 05/2020
2Retinal Diseases
01/2022 - 03/2016
1Glaucoma
11/2023
1Retinal Vein Occlusion
11/2023
1Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
01/2023
1Rupture
01/2023
1Dehydration (Water Stress)
11/2022
1Epiretinal Membrane (Epiretinal Membranes)
11/2022
1Central Serous Chorioretinopathy
09/2022
1Disease Progression
01/2021
1Inflammation (Inflammations)
01/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018
1Breast Neoplasms (Breast Cancer)
01/2017
1Retinal Dystrophies
03/2016
1Retinitis Pigmentosa (Pigmentary Retinopathy)
03/2016
1Geographic Atrophy
01/2016
1Blindness (Hysterical Blindness)
01/2016
1Fibrosis (Cirrhosis)
11/2015
1Cysts
10/2015
1Hematoma
03/2015
1Diabetic Retinopathy (Retinopathy, Diabetic)
03/2015
1Hypercholesterolemia
06/2014
1Hypertension (High Blood Pressure)
06/2014
1Nevus (Nevi)
01/2009
1Scotoma (Scintillating Scotoma)
10/2003

Drug/Important Bio-Agent (IBA)

9Fluorescein (Funduscein)FDA LinkGeneric
11/2022 - 03/2015
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 03/2015
4Retinaldehyde (Retinal)IBA
11/2022 - 09/2010
4Ranibizumab (Lucentis)FDA Link
05/2020 - 01/2009
2Retinal Pigments (Pigments, Visual)IBA
01/2023 - 03/2016
2Complement System Proteins (Complement)IBA
01/2018 - 01/2016
1Proteins (Proteins, Gene)FDA Link
11/2023
15,11-methenyltetrahydrohomofolateIBA
11/2023
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2023
1phytobacteriomycin (PBM)IBA
01/2023
1tyramine-deoxysorbitolIBA
01/2022
1LipidsIBA
01/2021
1afliberceptIBA
05/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1TamoxifenFDA LinkGeneric
01/2017
1Docetaxel (Taxotere)FDA Link
01/2017
1MAP-kinase-activated kinase 3IBA
03/2016
1Biological FactorsIBA
01/2016
1Coloring Agents (Dyes)IBA
10/2015
1Infracyanine greenIBA
03/2015
1OilsIBA
06/2014
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
06/2014
1Bevacizumab (Avastin)FDA Link
09/2010
1Angiogenesis InhibitorsIBA
09/2010

Therapy/Procedure

4Therapeutics
01/2021 - 09/2010
4Intravitreal Injections
03/2015 - 01/2009
3Lasers (Laser)
09/2022 - 10/2003
2Traction
11/2022 - 01/2021
1Decompression
11/2023
1Trabeculectomy (Trabeculoplasty)
11/2023
1Photochemotherapy (Photodynamic Therapy)
01/2023
1Low-Level Light Therapy (LLLT)
01/2023
1Laser Therapy (Surgery, Laser)
11/2021
1Vitreoretinal Surgery
01/2021
1Injections
01/2014
1Light Coagulation
10/2003